Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Promoting Activity After COPD Exacerbations, Aim 2 (PACE2)

NCT03793192 is registered in ClinicalTrials.gov with University of Illinois at Chicago as lead sponsor.

NCT NCT03793192
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03793192 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Promoting Activity After COPD Exacerbations, Aim 2 (PACE2)
Lead sponsor
University of Illinois at Chicago
Phase
Not applicable
Overall status
Terminated
Start date
March 18, 2019
Completion date
April 8, 2022
Enrollment
7 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic obstructive pulmonary disease